NaNotics LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NaNotics LLC - overview
Established
2015
Location
Mill Valley, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2015, NaNotics LLC is a preclinical stage company that is the developer of a nano-medical platform for the treatment of autoimmune disorders and solid tumour cancers. In October 2023, NaNotics LLC raised venture funding from investor LifeSpan Vision Ventures. As of October 2023, the company is led by CEO Lou Hawthorne. The company offers NaNots, a subtractive nanoparticle that treats disease by capturing and clearing pathogenic molecules from the blood to deplete soluble targets without interacting with the membrane forms of the same target.
The company is advancing a pipeline of NaNots targeting oncology and inflammatory markers associated with multiple diseases that present substantial unmet medical needs. The company plans to use the October 2023 funding to grow its development activities.
Current Investors
LifeSpan Vision Ventures
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.nanotics.com/
Verticals
Nanotechnology
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.